Effectiveness of induction therapy with exclusive enteral nutrition in pediatric Crohn's disease.
10.7499/j.issn.1008-8830.2201065
- Author:
You-You LUO
1
;
You-Hong FANG
1
;
Jin-Dan YU
1
;
Luo-Jia XU
1
;
Ming-Fang SUN
1
;
Qi CHENG
1
;
Jie CHEN
1
Author Information
1. Department of Gastroenterology, Children's Hospital, Zhejiang University School of Medicine/National Clinical Research Center for Child Health, Hangzhou 310052, China.
- Publication Type:Journal Article
- Keywords:
Child;
Crohn's disease;
Exclusive enteral nutrition;
Remission induction
- MeSH:
Adolescent;
Child;
Crohn Disease/therapy*;
Enteral Nutrition;
Female;
Humans;
Induction Chemotherapy;
Male;
Retrospective Studies
- From:
Chinese Journal of Contemporary Pediatrics
2022;24(6):626-630
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVES:To evaluate the effectiveness of induction therapy with exclusive enteral nutrition (EEN) in pediatric Crohn's disease (CD).
METHODS:A retrospective analysis was performed on the medical data of 62 children with CD who received EEN in Children's Hospital, Zhejiang University School of Medicine, from March 2013 to August 2021. The medical data included general information and height, weight, Pediatric Crohn's Disease Activity Index (PCDAI), Crohn's Disease Endoscopic Index of Severity, C-reactive protein, erythrocyte sedimentation rate, and serum albumin level before treatment and after 8 weeks of treatment. The changes in the above indicators were compared before and after treatment.
RESULTS:Among the 62 children with CD, there were 39 boys (63%) and 23 girls (37%), with a mean age of (11.9±3.0) years at diagnosis. Among the 55 children who completed EEN treatment for at least 8 weeks, 48 (87%) achieved clinical remission at week 8. PCDAI at week 8 was significantly lower than that before treatment (P<0.001). Except for 17 children with involvement of the small intestine alone and 3 children with involvement of the colon who did not receive colonoscopy reexamination, the remaining 35 children with involvement of the colon received colonoscopy reexamination after the 8-week EEN treatment. Of the 35 children, 29 (83%) achieved mucosal healing. As for the 48 children who achieved clinical remission at week 8, there were significant improvements in height-for-age Z-score and body mass index-for-age Z-score at week 8 (P<0.01). As for the 7 children who did not achieve clinical remission at week 8, there were no significant changes in height-for-age Z-score and body mass index-for-age Z-score at week 8 (P>0.05).
CONCLUSIONS:The 8-week EEN treatment has a good effect on clinical remission and mucosal healing in children with CD. For the children with CD achieving clinical remission, EEN can improve their height and body mass index.
